BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 12961962)

  • 1. Heightening awareness of myasthenia gravis, its presentation, symptoms and new treatments that are now available.
    J Ir Dent Assoc; 2003; 49(2):58-9. PubMed ID: 12961962
    [No Abstract]   [Full Text] [Related]  

  • 2. Myasthenia gravis: a real emergency.
    Kutzin JM
    Int Emerg Nurs; 2012 Apr; 20(2):102-5. PubMed ID: 22483007
    [No Abstract]   [Full Text] [Related]  

  • 3. A cause of reversible dysphagia: an unusual presentation of myasthenia gravis.
    Brostoff JM; Dahdaleh D; Birns J
    Eur J Intern Med; 2008 Jan; 19(1):70. PubMed ID: 18206608
    [No Abstract]   [Full Text] [Related]  

  • 4. Early onset myasthenia gravis with atypical features.
    Agarwal P; Chapagain U; Deewan KR; Rana PV
    Kathmandu Univ Med J (KUMJ); 2008; 6(2):231-4. PubMed ID: 18769095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current treatment of myasthenia gravis].
    de Assis JL
    Rev Paul Med; 1965 Oct; 67(4):231-42. PubMed ID: 5848156
    [No Abstract]   [Full Text] [Related]  

  • 6. Myasthenia gravis in a one year eight months old female child.
    Karmakar BC; Sinhamahapatra TK; Mallick AK; Das GC
    J Indian Med Assoc; 2011 Aug; 109(8):595. PubMed ID: 22315873
    [No Abstract]   [Full Text] [Related]  

  • 7. [Dysphagia as the sole manifestation of myasthenia gravis].
    Romo González RJ; Chaves E; Copello H
    Acta Gastroenterol Latinoam; 2010 Jun; 40(2):156-8. PubMed ID: 20645565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Teaching NeuroImages: reversible ectropion in myasthenia gravis.
    Solé G; Perez F; Ferrer X
    Neurology; 2009 Oct; 73(16):e83. PubMed ID: 19841376
    [No Abstract]   [Full Text] [Related]  

  • 9. Dysphonia as first symptom of late-onset myasthenia gravis.
    Montero-Odasso M
    J Gen Intern Med; 2006 Jun; 21(6):C4-6. PubMed ID: 16808732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-varicella myasthenia gravis.
    Saha A; Batra P; Vilhekar KY; Chaturvedi P
    Singapore Med J; 2007 Jun; 48(6):e177-80. PubMed ID: 17538742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits from sustained-release pyridostigmine bromide in myasthenia gravis: results of a prospective multicenter open-label trial.
    Sieb JP; Köhler W
    Clin Neurol Neurosurg; 2010 Nov; 112(9):781-4. PubMed ID: 20663605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An unusual presentation of myasthenia gravis.
    Chijoke A; Ogunmodele JA
    West Afr J Med; 2009; 28(6):391-3. PubMed ID: 20486100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myasthenia gravis accompanied with hypokalemic periodic paralysis.
    Sawanyawisuth K; Tiamkao S; Pratipanawatr T
    J Med Assoc Thai; 2006 May; 89(5):727-9. PubMed ID: 16756062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic challenge: Myasthenia gravis in the emergency department.
    Abbott SA
    J Am Acad Nurse Pract; 2010 Sep; 22(9):468-73. PubMed ID: 20854638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single fibre EMG in juvenile myasthenia gravis.
    Stalberg E; Hansson O
    Neuropadiatrie; 1973 Jan; 4(1):20-9. PubMed ID: 4349293
    [No Abstract]   [Full Text] [Related]  

  • 16. Myasthenia gravis and glycopyrrolate.
    Marcus E; Wayne F
    S Afr Med J; 1981 Oct; 60(17):650. PubMed ID: 7302713
    [No Abstract]   [Full Text] [Related]  

  • 17. [Myasthenia gravis in Santo Tomás Hospital 1990-1997].
    Frago G; Gracia F; Chang E; Andrade Alegre R
    Rev Med Panama; 1998 Sep; 23(2):15-9. PubMed ID: 11214554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celebrating the 70 years of pyridostigmine on therapy of Myasthenia Gravis: historical aspects of the preliminary trials.
    Lorenzoni PJ; Kay CSK; Ducci RD; Fustes OJH; Werneck LC; Scola RH
    Arq Neuropsiquiatr; 2020 Mar; 78(3):179-181. PubMed ID: 32215460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of myasthenia. II.
    Br Med J; 1971 Apr; 2(5755):213-4. PubMed ID: 5575956
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of use of pyridostigmine and requirement of vecuronium in patients with myasthenia gravis.
    Tripathi M; Kaushik S; Dubey P
    J Postgrad Med; 2003; 49(4):311-4; discussion 314-5. PubMed ID: 14699228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.